Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration

Journal of Bone and Mineral Research

Volumn 25, Issue 11, 2010, Pages 2350-2358

  Leslie, William D ^a   Lix, Lisa M ^b   Johansson, Helena ^c   Oden, Anders ^c   McCloskey, Eugene ^d   Kanis, John A ^e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Consulting Statistician ^*  (Sweden)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

administrative data; bone mineral density; dual x ray absorptiometry; fractures; frax; historical cohort study; osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CALIBRATION; CANADA; CLINICAL ASSESSMENT TOOL; DATA BASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL MODEL; VALIDATION PROCESS;

AGED; BONE DENSITY; CALIBRATION; CANADA; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 78349239244     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.123     Document Type: Article

References (47)

1. Tenenhouse A, Joseph L, Kreiger N, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2000; 11: 897 -904.
2. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos M,. Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporosis Int. 2001; 12: 271 -278.
3. Papaioannou A, Adachi JD, Parkinson W, Stephenson G, Bedard M,. Lengthy hospitalization associated with veretebral fractures despite control for comorbid conditions. Osteoporosis Int. 2001; 12: 870 -874.
4. Ioannidis G, Papaioannou A, Hopman WM, et al. Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. Can Med Assoc J. 2009; 181: 265 -271.
5. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA,. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999; 353: 878 -882.
6. Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004; 15: 38 -42.
7. Adachi JD, Ioannidis G, Berger C, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001; 12: 903 -908.
8. Hallberg I, Rosenqvist AM, Kartous L, Lofman O, Wahlstrom O, Toss G,. Health-related quality of life after osteoporotic fractures. Osteoporos Int. 2004; 15: 834 -841.
9. Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A,. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int. 2001; 12: 417 -427.
10. Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005; 16: 581 -589.
11. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E,. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19: 385 -397.
12. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 1033 -1046.
13. Dawson-Hughes B,. A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab. 2008; 93: 2463 -2465.
14. Dawson-Hughes B, Tosteson AN, Melton LJ III, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008; 19: 449 -458.
15. Fujiwara S, Nakamura T, Orimo H, et al. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int. 2008; 19: 429 -435.
16. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A,. Case finding for the management of osteoporosis with FRAX((R))-assessment and intervention thresholds for the UK. Osteoporos Int. 2008; 19: 1395 -1408.
17. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK,. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002; 17: 1237 -1244.
18. Leslie WD, O'Donnell S, Lagace C, et al. Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int. 2010; 21: 1317 -1322.
19. Dawson-Hughes B, Looker AC, Tosteson AN, Johansson H, Kanis JA, Melton LJ III., The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int. 2010; 21: 41 -52.
20. Kanis JA, Johansson H, Oden A, Dawson-Hughes B, Melton LJ III, McCloskey EV,. The effects of a FRAX((R)) revision for the USA. Osteoporos Int. 2010; 21: 35 -40.
21. Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton LJ III., Updated fracture incidence rates for the US version of FRAX(R). Osteoporos Int. 2010; 21: 25 -33.
22. Richards J, Brown A, Homan C,. The data quality study of the Canadian discharge abstract database: a methodological perspective. Proceedings of Statistics Canada Symposium: Achieving data quality in a statistical agency. Statistics Canada, Ottawa [serial online] Available at: Accessed June 6, 2009.
23. Canadian Institute for Health Information Quality Assurance Processes Applied to the Discharge Abstract and Hospital Morbidity Databases. CIHI, Ottawa [serial online] Available at:. Accessed August 3, 2009.
24. Leslie WD, Metge C,. Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom. 2003; 6: 275 -282.
25. Leslie WD, MacWilliam L, Lix L, Caetano P, Finlayson GS,. A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int. 2005; 16: 773 -782.
26. Leslie WD, Caetano PA, MacWilliam LR, Finlayson GS,. Construction and validation of a population-based bone densitometry database. J Clin Densitom. 2005; 8: 25 -30.
27. Hansen KE, Binkley N, Christian R, et al. Interobserver reproducibility of criteria for vertebral body exclusion. J Bone Miner Res. 2005; 20: 501 -508.
28. Leslie WD,. The importance of spectrum bias on bone density monitoring in clinical practice. Bone. 2006; 39: 361 -368.
29. Roos NP, Shapiro E,. Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system. Med Care. 1999; 37: JS10 -JS14.
30. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo: 2005.
31. Kozyrskyj AL, Mustard CA,. Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998; 32: 1152 -1157.
32. Leslie WD, Tsang JF, Caetano PA, Lix LM,. Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab. 2007; 92: 77 -81.
33. Steyerberg EW,. Clinical prediction models: A practical approach to development, validation, and updating. New York: Springer, 2008.
34. Moons KG, Altman DG, Vergouwe Y, Royston P,. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009; 338: 1487 -1490.
35. Altman DG, Vergouwe Y, Royston P, Moons KG,. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009; 338: 1432 -1435.
36. Royston P, Moons KG, Altman DG, Vergouwe Y,. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009; 338: 1373 -1377.
37. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG,. Prognosis and prognostic research: what, why, and how? BMJ. 2009; 338: 1317 -1320.
38. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004; 19: 893 -899. (Pubitemid 41103445)
39. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004; 35: 375 -382. (Pubitemid 38953182)
40. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int. 2005; 16: 737 -742.
41. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005; 16: 155 -162.
42. Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D,. Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int. 2001; 69: 218 -221.
43. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N,. A reference standard for the description of osteoporosis. Bone. 2008; 42: 467 -475.
44. Kanis JA, Johnell O, Oden A, et al. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int. 2006; 17: 527 -534.
45. Leslie WD, Lix LM, Tsang JF, Caetano PA,. Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med. 2007; 167: 1641 -1647.
46. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998; 128: 793 -800.
47. Leslie WD, Tsang JF, Lix LM,. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program. Bone. 2008; 43: 667 -671.